Lyme Disease Clinical Trial
Official title:
PET and MRI Imaging of Persistent Lyme Encephalopathy
The purpose of this study is to determine whether patients with persistent memory problems after Lyme disease benefit from an additional longer course of IV antibiotic therapy; to use modern brain imaging technology to determine whether the problem in the central nervous system is primarily one of poor blood flow or one of impaired nerve cell functioning; and to try to identify biological markers prior to treatment that will identify patients who are more or less likely to respond to the study treatment.
Some people with a history of Lyme disease continue to have problems despite having received
“textbook duration” antibiotic therapy. When memory, attention, or thinking problems
persist, the syndrome is called persistent Lyme disease (PLD). This study seeks to answer
critical scientific questions about the treatment and cause of PLD symptoms.
This 24-week treatment study will evaluate each patient’s response to treatment using
neuropsychological testing and state-of-the-art brain imaging. The brain tests include
neuropsychological testing of memory and attention, brain imaging (MRI and PET scans) to
look at blood flow in the brain and nerve cell structure and metabolism, a neurological
exam, and studies of the fluid that surrounds the brain (cerebrospinal fluid). The treatment
involves 10 weeks of either intravenous antibiotic called ceftriaxone (also known as
Rocephin) or intravenous placebo (inactive substance). After the first visit to Columbia
Presbyterian Medical Center, the remaining treatments will be done in the patient’s home.
Patients will be screened over the phone and in person to confirm study eligibility.
;
Allocation: Randomized, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01207739 -
Persistent Lyme Empiric Antibiotic Study Europe
|
Phase 4 | |
| Terminated |
NCT04577053 -
PEMF Therapy to Treat Lingering Symptoms of Lyme Disease After Treatment With Antibiotics
|
N/A | |
| Completed |
NCT04867473 -
Feasibility of Teleyoga for Treatment of Lyme Disease
|
N/A | |
| Recruiting |
NCT04038346 -
Symptomatic Management of Lyme Arthritis
|
Phase 3 | |
| Completed |
NCT01143558 -
Searching for Persistence of Infection in Lyme Disease
|
Early Phase 1 | |
| Withdrawn |
NCT04318925 -
Evaluation and Follow-up of People With Tick-borne Diseases
|
||
| Terminated |
NCT03581279 -
Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel
|
N/A | |
| Enrolling by invitation |
NCT05041595 -
Lyme Disease Diagnostic Assay - Collection of Whole Blood
|
||
| Recruiting |
NCT03981874 -
Peripheral Facial Paralysis Sequelae in Lyme Disease Among Children
|
N/A | |
| Recruiting |
NCT03963635 -
Novel Diagnostics for Early Lyme Disease
|
||
| Terminated |
NCT03084614 -
CD8 Reactivity to Microorganisms in Blood and Breast Milk
|
||
| Recruiting |
NCT04835792 -
Biomarker Study of Previously Treated Lyme Disease Volunteers in Comparison to Healthy Volunteers
|
||
| Recruiting |
NCT06397794 -
Navigating Pregnancy and Parenthood With Lyme Disease
|
||
| Recruiting |
NCT04148222 -
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Lyme Disease
|
||
| Terminated |
NCT03201042 -
Lyme Test Indication Combinations (LyTIC) Study
|
||
| Completed |
NCT01368341 -
Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice
|
Phase 4 | |
| Terminated |
NCT00958139 -
Passive Prophylaxis of Lyme Disease Using Permethrin Treated Clothes
|
Phase 3 | |
| Recruiting |
NCT00001539 -
A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations
|
||
| Recruiting |
NCT03501407 -
Understanding Tick-borne Diseases
|
||
| Completed |
NCT04422314 -
ImmuneSense Lyme Study
|